Hudson Bay Capital Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50,249
| Closed | -$727K | – | 767 |
|
|
2024
Q2 | $727K | Sell |
50,249
-221,001
| -81% | -$3.2M | ﹤0.01% | 508 |
|
|
2024
Q1 | $4.2M | Buy |
271,250
+55,230
| +26% | +$855K | 0.02% | 283 |
|
|
2023
Q4 | $6.05M | Buy |
216,020
+116,030
| +116% | +$3.25M | 0.04% | 234 |
|
|
2023
Q3 | $4.76M | Buy |
99,990
+55,990
| +127% | +$2.67M | 0.04% | 258 |
|
|
2023
Q2 | $4.22M | Buy |
44,000
+17,750
| +68% | +$1.7M | 0.03% | 297 |
|
|
2023
Q1 | $2.98M | Sell |
26,250
-2,750
| -9% | -$312K | 0.02% | 402 |
|
|
2022
Q4 | $3.25M | Buy |
29,000
+10,755
| +59% | +$1.2M | 0.03% | 457 |
|
|
2022
Q3 | $2.34M | Sell |
18,245
-17,860
| -49% | -$2.29M | 0.02% | 661 |
|
|
2022
Q2 | $2.48M | Buy |
36,105
+28,605
| +381% | +$1.96M | 0.02% | 689 |
|
|
2022
Q1 | $1.07M | Buy |
7,500
+2,500
| +50% | +$356K | 0.01% | 786 |
|
|
2021
Q4 | $833K | Sell |
5,000
-18,500
| -79% | -$3.08M | 0.01% | 797 |
|
|
2021
Q3 | $3.27M | Buy |
+23,500
| New | +$3.27M | 0.04% | 484 |
|